RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+4.61%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$49.6B
AUM Growth
+$1.7B
(+3.6%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
16.96%
Holding
3,019
New
199
Increased
1,870
Reduced
823
Closed
112
Top Buys
| 1 |
AT&T
T
|
+$59.6M |
| 2 |
Microsoft
MSFT
|
+$29.6M |
| 3 |
Amazon
AMZN
|
+$27.6M |
| 4 |
Evergy
EVRG
|
+$27.5M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$22M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$130M |
| 2 |
MON
Monsanto Co
MON
|
+$88.9M |
| 3 |
Apple
AAPL
|
+$21.6M |
| 4 |
Keurig Dr Pepper
KDP
|
+$18.7M |
| 5 |
Gilead Sciences
GILD
|
+$16.3M |
Sector Composition
| 1 | Technology | 17.47% |
| 2 | Financials | 16.24% |
| 3 | Healthcare | 13.05% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
1626
DELISTED
Faro Technologies
FARO
| $2.2M | ﹤0.01% |
40,549
+518
| +1% | +$28.2K |
|
1627
Moelis & Co
MC
$5.54B
| $2.2M | ﹤0.01% |
37,470
+9,192
| +33% | +$539K |
|
|
GBT
1628
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.2M | ﹤0.01% |
48,618
+12,622
| +35% | +$571K |
|
1629
Extreme Networks
EXTR
$2.95B
| $2.2M | ﹤0.01% |
276,065
+12,164
| +5% | +$96.8K |
|
1630
SunCoke Energy
SXC
$654M
| $2.2M | ﹤0.01% |
163,902
+3,834
| +2% | +$51.4K |
|
1631
Heartland Express
HTLD
$656M
| $2.19M | ﹤0.01% |
118,036
+819
| +0.7% | +$15.2K |
|
|
DBD
1632
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.19M | ﹤0.01% |
183,148
+51,976
| +40% | +$621K |
|
1633
Premier
PINC
$2.2B
| $2.19M | ﹤0.01% |
60,145
-4,711
| -7% | -$171K |
|
1634
Ormat Technologies
ORA
$5.53B
| $2.18M | ﹤0.01% |
41,048
+1,307
| +3% | +$69.5K |
|
1635
Super Micro Computer
SMCI
$26.7B
| $2.18M | ﹤0.01% |
923,160
+14,930
| +2% | +$35.3K |
|
1636
Liberty Latin America Class C
LILAK
$1.53B
| $2.17M | ﹤0.01% |
+118,749
| New | +$2.17M |
|
1637
NovoCure
NVCR
$1.36B
| $2.17M | ﹤0.01% |
69,161
+14,651
| +27% | +$459K |
|
|
BNFT
1638
DELISTED
Benefitfocus, Inc.
BNFT
| $2.16M | ﹤0.01% |
64,412
+37,823
| +142% | +$1.27M |
|
|
CLVS
1639
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.16M | ﹤0.01% |
47,586
+4,110
| +9% | +$187K |
|
1640
Shutterstock
SSTK
$742M
| $2.15M | ﹤0.01% |
45,396
+2,455
| +6% | +$116K |
|
1641
Ambac
AMBC
$413M
| $2.15M | ﹤0.01% |
108,325
+63,529
| +142% | +$1.26M |
|
1642
Rayonier Advanced Materials
RYAM
$421M
| $2.14M | ﹤0.01% |
125,460
+7,982
| +7% | +$136K |
|
|
UHT
1643
Universal Health Realty Income Trust
UHT
$575M
| $2.14M | ﹤0.01% |
33,445
+1,582
| +5% | +$101K |
|
|
MAGN
1644
Magnera Corporation
MAGN
$393M
| $2.13M | ﹤0.01% |
8,380
+21
| +0.3% | +$5.35K |
|
1645
Pathward Financial
CASH
$1.72B
| $2.13M | ﹤0.01% |
65,622
+1,281
| +2% | +$41.6K |
|
|
NAV
1646
DELISTED
Navistar International
NAV
| $2.13M | ﹤0.01% |
52,317
-166
| -0.3% | -$6.76K |
|
|
ARNA
1647
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.12M | ﹤0.01% |
48,581
+10,883
| +29% | +$474K |
|
1648
Alamo Group
ALG
$2.49B
| $2.11M | ﹤0.01% |
23,344
+718
| +3% | +$64.9K |
|
|
LGF.B
1649
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.11M | ﹤0.01% |
89,735
-11,855
| -12% | -$278K |
|
1650
WesBanco
WSBC
$3.03B
| $2.09M | ﹤0.01% |
46,501
+3,231
| +7% | +$145K |
|